Photodermatitis from plant derivatives in topical and oral medicaments.
Fernández de Corrès
L
L
Servicio de Alergología, Hospital Santiago Apostol, Spain.
Díez
J M
JM
Audicana
M
M
García
M
M
Muñoz
D
D
Fernández
E
E
Etxenagusía
M
M
D000433:1-Propanol / Q000009:adverse effects; D000171:Acrolein / Q000009:adverse effects / Q000031:analogs & derivatives; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000328:Adult; D001453:Balsams / Q000009:adverse effects; D001547:Benzaldehydes / Q000009:adverse effects; D005054:Eugenol / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D005421:Flavoring Agents / Q000009:adverse effects; D006722:Honey / Q000009:adverse effects; D006801:Humans; D010476:Perfume / Q000009:adverse effects; D010787:Photosensitivity Disorders / Q000209:etiology*; D010936:Plant Extracts / Q000009:adverse effects*; D020005:Propanols; D011429:Propolis / Q000009:adverse effects; D012116:Resins, Plant / Q000009:adverse effects*
D001453:Balsams; D001547:Benzaldehydes; D005421:Flavoring Agents; D010476:Perfume; D010936:Plant Extracts; D020005:Propanols; D012116:Resins, Plant; D005054:Eugenol; C036643:isoeugenol; D000171:Acrolein; C025080:Peruvian balsam; D011429:Propolis; D000433:1-Propanol; C100058:vanillin; C012843:cinnamaldehyde; C020722:cinnamyl alcohol